Company

Company

Remimazolam

Remimazolam

Media and Investors

Media and Investors

PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs for out-patient and hospital-based sedation, anesthesia and critical care services.

 

Learn more About PAION

news

12/01/2020

DR. JUERGEN BECK WILL LEAVE THE PAION AG MANAGEMENT BOARD ON 31 DECEMBER 2020 AS...

DGAP-News: PAION AG / Key word(s): Personnel 01.12.2020 / 14:00 ...

Read more
11/19/2020

PAION REPORTS POSITIVE REMIMAZOLAM TOPLINE DATA IN EU PHASE III TRIAL IN GENERAL...

DGAP-News: PAION AG / Key word(s): Research Update 19.11.2020 /...

Read more
11/19/2020

PAION REPORTS POSITIVE REMIMAZOLAM TOPLINE DATA IN EU PHASE III TRIAL IN GENERAL...

PAION AG / Key word(s): Research Update PAION REPORTS POSITIVE...

Read more
To the newsroom

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.

 

Visit us on LinkedIn!
LinkedIn